---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-305467"
form_type: "8-K"
ticker: "CRDF"
cik: "0001213037"
company_name: "Cardiff Oncology, Inc."
filed_at: "2026-07-16T12:38:12+00:00"
generated_at: "2026-07-16T12:40:36.513643+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cardiff Oncology raises ~$10M in registered direct offering of common stock and warrants

## Summary
- Sold 8,571,429 shares at $1.05/share with warrants for 8,571,429 shares at $1.31 exercise price.
- Insiders purchased 731,707 shares at $1.435/share with warrants; total gross proceeds ~$10M.
- Warrants exercisable after six months and authorized share increase; expire 5.5 years from start.
- Net proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; closing expected July 16, 2026.

## SEC filing metadata
- accession: 0001193125-26-305467
- form_type: 8-K
- ticker: CRDF
- cik: 0001213037
- company_name: Cardiff Oncology, Inc.
- filed_at: 2026-07-16T12:38:12+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/0001193125-26-305467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1213037/000119312526305467/crdf-20260714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-305467
- JSON: https://secwatch.observer/filing/0001193125-26-305467.json
- Plain text: https://secwatch.observer/filing/0001193125-26-305467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.